Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Clovis Oncology Announces First Patient Enrolled In Phase 2 Portion Of The LIO-1 Trial Evaluating The Combination Of Lucitanib And Opdivo In Gynecologic Cancers


Benzinga | Aug 5, 2020 08:12AM EDT

Clovis Oncology Announces First Patient Enrolled In Phase 2 Portion Of The LIO-1 Trial Evaluating The Combination Of Lucitanib And Opdivo In Gynecologic Cancers






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC